{"log_id": 3578543369796510235, "direction": 0, "words_result_num": 54, "words_result": [{"probability": {"variance": 0.025067, "average": 0.898757, "min": 0.467419}, "location": {"width": 451, "top": 214, "height": 55, "left": 205}, "words": "或5-羟色类制剂有潜在的村互作用"}, {"probability": {"variance": 0.017654, "average": 0.886355, "min": 0.578664}, "location": {"width": 228, "top": 268, "height": 38, "left": 208}, "words": "肾上腺家能类药物:"}, {"probability": {"variance": 0.025492, "average": 0.905581, "min": 0.425359}, "location": {"width": 1031, "top": 281, "height": 67, "left": 263}, "words": "当健康受试者同时接受利杂唑及超过100mg的胺时,可见显的培压反应。所以"}, {"probability": {"variance": 0.026582, "average": 0.909599, "min": 0.368347}, "location": {"width": 1104, "top": 319, "height": 73, "left": 208}, "words": "应用利奈唑的法老应避免食用含量高的食物或饮科(尼【注意事项】中的患者用药信"}, {"probability": {"variance": 0.003902, "average": 0.928424, "min": 0.865956}, "location": {"width": 49, "top": 400, "height": 29, "left": 210}, "words": "息)"}, {"probability": {"variance": 0.024018, "average": 0.903541, "min": 0.449865}, "location": {"width": 1044, "top": 402, "height": 69, "left": 270}, "words": "对血压正常的健康志愿者端下利唑胺,可观察到利按能可逆栏地培伪麻黄碱"}, {"probability": {"variance": 0.030703, "average": 0.898879, "min": 0.37872}, "location": {"width": 1073, "top": 442, "height": 73, "left": 239}, "words": "SE、盐酸本内胺(PPA)的增压作用(见【注意事项】中的药物相互作用).未对血"}, {"probability": {"variance": 0.020775, "average": 0.910319, "min": 0.384281}, "location": {"width": 1102, "top": 487, "height": 71, "left": 210}, "words": "压患者进行训的研究。对血压正常的健志者进行了利奈唑、PSE、A、女慰剂分别"}, {"probability": {"variance": 0.023208, "average": 0.874135, "min": 0.526346}, "location": {"width": 322, "top": 552, "height": 46, "left": 214}, "words": "单用,及利奈唑胺达稳态时"}, {"probability": {"variance": 0.023472, "average": 0.900661, "min": 0.386388}, "location": {"width": 702, "top": 527, "height": 60, "left": 612}, "words": "g,每12小时一次:连用3联用PSE或PA(PA5mg)"}, {"probability": {"variance": 0.020104, "average": 0.897451, "min": 0.696932}, "location": {"width": 80, "top": 606, "height": 29, "left": 214}, "words": "或SE"}, {"probability": {"variance": 0.024299, "average": 0.922849, "min": 0.394593}, "location": {"width": 939, "top": 568, "height": 69, "left": 378}, "words": "各二个剂量,给药间隔÷小时对血压和心率的影的切究,任何给药方式心"}, {"probability": {"variance": 0.033662, "average": 0.884936, "min": 0.368626}, "location": {"width": 1109, "top": 610, "height": 71, "left": 212}, "words": "率均不受影响。利奈按与PPA或SE联均能速直上升:在PPA或PSE第一次给药后的"}, {"probability": {"variance": 0.018859, "average": 0.92008, "min": 0.427329}, "location": {"width": 1107, "top": 650, "height": 73, "left": 216}, "words": "2-3小时,观察到最高的血压值:达峰伯后的2一3小时:血又回复到了基础水平。PA"}, {"probability": {"variance": 0.011411, "average": 0.942103, "min": 0.464173}, "location": {"width": 867, "top": 702, "height": 62, "left": 216}, "words": "引究结果表明:平均(范围)最大缩压mHg表示为:玄慰剂-121"}, {"probability": {"variance": 0.000792, "average": 0.951678, "min": 0.915041}, "location": {"width": 129, "top": 695, "height": 33, "left": 1192}, "words": "58),利奈"}, {"probability": {"variance": 0.029493, "average": 0.865115, "min": 0.404486}, "location": {"width": 1100, "top": 735, "height": 69, "left": 225}, "words": "唑按卓书=120(107135);PPA单用=125(106-139),PA与利杂胶联=147(129"}, {"probability": {"variance": 0.033049, "average": 0.867626, "min": 0.41251}, "location": {"width": 1096, "top": 776, "height": 69, "left": 225}, "words": "一17E).PE的证究结果与PPA的研究结果相似。当利东唑与P或平A联用时;软基码"}, {"probability": {"variance": 0.042667, "average": 0.89444, "min": 0.371082}, "location": {"width": 597, "top": 832, "height": 53, "left": 221}, "words": "收缩压的平均最大增加但分别为32mm范:20"}, {"probability": {"variance": 0.039125, "average": 0.834574, "min": 0.410271}, "location": {"width": 230, "top": 820, "height": 44, "left": 912}, "words": "g)和38H(范围"}, {"probability": {"variance": 0, "average": 0.972145, "min": 0.972145}, "location": {"width": 22, "top": 825, "height": 22, "left": 1299}, "words": ")"}, {"probability": {"variance": 0.046911, "average": 0.79852, "min": 0.363041}, "location": {"width": 317, "top": 881, "height": 44, "left": 228}, "words": "5-色胺类物的茫留"}, {"probability": {"variance": 0.031309, "average": 0.89066, "min": 0.433089}, "location": {"width": 1051, "top": 894, "height": 73, "left": 279}, "words": "对康怎者进行了利奈唑与右美沙芬潜在药物相互作用的研究给予志愿者右美沙"}, {"probability": {"variance": 0.037092, "average": 0.836223, "min": 0.387152}, "location": {"width": 1107, "top": 937, "height": 71, "left": 225}, "words": "芬(二个剂量,每次2ng:间隔4小时,同时给予或不给予利奈唑股,受美沙芬"}, {"probability": {"variance": 0.029238, "average": 0.887519, "min": 0.376927}, "location": {"width": 1073, "top": 979, "height": 69, "left": 228}, "words": "利奈唑胺的血压正常的志者中木观察到5羟色胺综合征的作用(总识模糊、极度兴奋"}, {"probability": {"variance": 0.028413, "average": 0.901759, "min": 0.424406}, "location": {"width": 496, "top": 1037, "height": 51, "left": 230}, "words": "不空、、潮红,发汗以及体温升高"}, {"probability": {"variance": 6.1e-05, "average": 0.994285, "min": 0.97743}, "location": {"width": 154, "top": 1129, "height": 35, "left": 239}, "words": "【药物过量】"}, {"probability": {"variance": 0.03056, "average": 0.898708, "min": 0.386663}, "location": {"width": 1049, "top": 1138, "height": 71, "left": 288}, "words": "在过至事件,建议应用支持疗法,雏持肾小球的滤过,血液透析能加速利唑胺的清"}, {"probability": {"variance": 0.033127, "average": 0.875484, "min": 0.398357}, "location": {"width": 1109, "top": 1178, "height": 76, "left": 230}, "words": "除:在I期临研究中,给予刺奈唑胺3小时后,通过3小时的血液透析,30%剂量的药物"}, {"probability": {"variance": 0.019315, "average": 0.885046, "min": 0.479006}, "location": {"width": 1104, "top": 1219, "height": 76, "left": 234}, "words": "被清除、尚无医膜透析血液滤过清除利杂唑胺的资料,当分别给予300mg/kg/天和"}, {"probability": {"variance": 0.030565, "average": 0.876972, "min": 0.425486}, "location": {"width": 1102, "top": 1261, "height": 73, "left": 237}, "words": "20mgkg/天的奈唑时,动物急性中的临症状为大鼠活动力下降和运动失词,为出"}, {"probability": {"variance": 0.030947, "average": 0.911206, "min": 0.518176}, "location": {"width": 172, "top": 1335, "height": 38, "left": 237}, "words": "現呕吐和颤抖"}, {"probability": {"variance": 0, "average": 0.952166, "min": 0.952166}, "location": {"width": 172, "top": 1306, "height": 73, "left": 1248}, "words": "分"}, {"probability": {"variance": 0, "average": 0.822473, "min": 0.822473}, "location": {"width": 46, "top": 1373, "height": 42, "left": 1391}, "words": "己"}, {"probability": {"variance": 0.001517, "average": 0.981655, "min": 0.894569}, "location": {"width": 154, "top": 1418, "height": 33, "left": 248}, "words": "【临床研究】"}, {"probability": {"variance": 0.003133, "average": 0.958905, "min": 0.879751}, "location": {"width": 84, "top": 1460, "height": 33, "left": 241}, "words": "成年人"}, {"probability": {"variance": 0, "average": 0.963579, "min": 0.963579}, "location": {"width": 219, "top": 1395, "height": 105, "left": 1156}, "words": "★"}, {"probability": {"variance": 0.000748, "average": 0.983968, "min": 0.895958}, "location": {"width": 342, "top": 1491, "height": 49, "left": 241}, "words": "万古霉素耐药的肠球菌感染"}, {"probability": {"variance": 0.023315, "average": 0.894495, "min": 0.411041}, "location": {"width": 1046, "top": 1509, "height": 69, "left": 299}, "words": "切确或怀疑为万古素药的球菌感染的成年患者入选至一个随机、中心、双百"}, {"probability": {"variance": 0.018852, "average": 0.907207, "min": 0.416201}, "location": {"width": 1187, "top": 1536, "height": 87, "left": 243}, "words": "对照的研究中,以高剂量利唑胶(6001g12小时一次,口服或注)或低剂量利余唑"}, {"probability": {"variance": 0.048278, "average": 0.831227, "min": 0.359114}, "location": {"width": 1098, "top": 1592, "height": 71, "left": 243}, "words": "胺(2ng每2小时一次,口服或静注)疗了一28元:患名可合开应用白或基新"}, {"probability": {"variance": 0.036169, "average": 0.864729, "min": 0.379628}, "location": {"width": 1104, "top": 1632, "height": 71, "left": 243}, "words": "背立生素79例患者随进入岛剂组:66例患者随机入低剂只组,基统已定为万"}, {"probability": {"variance": 0.043145, "average": 0.849599, "min": 0.413223}, "location": {"width": 416, "top": 1695, "height": 46, "left": 248}, "words": "得素丽药球南感染的意向治疗"}, {"probability": {"variance": 0.082485, "average": 0.699346, "min": 0.412144}, "location": {"width": 20, "top": 1702, "height": 22, "left": 740}, "words": "t"}, {"probability": {"variance": 0.033143, "average": 0.871969, "min": 0.432156}, "location": {"width": 480, "top": 1675, "height": 49, "left": 874}, "words": "ITT)人包括高剂量组的人和低剂"}, {"probability": {"variance": 0.002531, "average": 0.964274, "min": 0.859622}, "location": {"width": 156, "top": 1744, "height": 33, "left": 248}, "words": "量组的52人"}, {"probability": {"variance": 0.029145, "average": 0.901332, "min": 0.374283}, "location": {"width": 1046, "top": 1753, "height": 73, "left": 308}, "words": "基线确定为万占霉素约的场球菌感染的IT人群中,不同感染的治愈率见表10。这"}, {"probability": {"variance": 0.027936, "average": 0.891147, "min": 0.4078}, "location": {"width": 1102, "top": 1796, "height": 69, "left": 252}, "words": "治愈率包括结果失或结果不确定的患者。高剂量组患老的治意率比低剂量组为高,但"}, {"probability": {"variance": 0.017834, "average": 0.93366, "min": 0.497316}, "location": {"width": 496, "top": 1856, "height": 51, "left": 250}, "words": "在C.05检验水平,此差别无统计学意义"}, {"probability": {"variance": 0.034786, "average": 0.866206, "min": 0.415584}, "location": {"width": 939, "top": 1869, "height": 127, "left": 400}, "words": "表1基线已确定为万古时药的肠球菌感染的IT成年患者"}, {"probability": {"variance": 0.00295, "average": 0.767022, "min": 0.712705}, "location": {"width": 134, "top": 1941, "height": 49, "left": 1239}, "words": "中心"}, {"probability": {"variance": 0.000914, "average": 0.97733, "min": 0.907509}, "location": {"width": 337, "top": 1972, "height": 46, "left": 639}, "words": "在治愈检测随访时的治愈率"}, {"probability": {"variance": 0.06254, "average": 0.808339, "min": 0.353489}, "location": {"width": 194, "top": 2022, "height": 29, "left": 711}, "words": "14页,共25"}, {"probability": {"variance": 0, "average": 0.393584, "min": 0.393584}, "location": {"width": 33, "top": 2024, "height": 33, "left": 1207}, "words": " PEI"}], "language": 3}